首页>
外国专利>
PRODUCTION OF NOVEL 17 BETAAESTER OF NANDROLONE AND NOVEL PHARMACEUTICAL AGENT CONTAINING SAME WITH ASSIMIRATING ACTION
PRODUCTION OF NOVEL 17 BETAAESTER OF NANDROLONE AND NOVEL PHARMACEUTICAL AGENT CONTAINING SAME WITH ASSIMIRATING ACTION
展开▼
机译:含同化作用的新农隆17甲酚酯的生产和含有相同成分的新药
展开▼
页面导航
摘要
著录项
相似文献
摘要
The invention relates to a novel pharmaceutical preparation with anabolic activity adapted for oral administration comprising a nandrolone (= 19-nor-testosterone)-17 beta -ester, the ester group of which has been derived from aliphatic carboxylic acids having 9-18 carbon atoms, in combination with a non-steroidal lipoid. The preparation may additionally contain a mineralocorticoid steroid. The invention also relates to novel nandrolone-17 beta -esters.
展开▼